In some cases, the systems that play a role in batch release — LIMS (laboratory information management system), MES (manufacturing ... and supplier sectors in biopharma saw a spat of notable ...

Zeeshan Saeed, CEO of Quantum BioPharma said, "We are thrilled and honored to welcome Kevin Malone as an advisor. His wealth of experience, especially in naked short squeeze strategies, will be an ...

The company has expanded its laboratories in the Virginia Biotechnology Research Park in Richmond, Virginia, by acquiring additional analytical capabilities, including advanced spectroscopy tools and ...

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline ...

Novo Nordisk (NYSE:NVO) has filed for U.S. approval of an oral version of its blockbuster weight loss drug Wegovy, the company confirmed to BioPharma Dive. The Danish drugmaker disclosed the ...

In recent years, the scale of biopharma investment into Ireland has accelerated, with some significant investments being made by the biggest companies in the industry. The country has always been ...

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year ...

“We are thrilled to partner with Paige to unlock new possibilities for biopharma researchers and clinicians,” Darragh McArt, CEO and founder of Sonrai Analytics, said in a press release (1). “By ...

Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

We hoped industry layoffs would relent in 2024. That's not what happened. Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. So, here we are ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...